Please login to the form below

Not currently logged in
Email:
Password:

myopia

This page shows the latest myopia news and features for those working in and with pharma, biotech and healthcare.

Loss aversion

Loss aversion

The outside view, however, is that our American neighbours struggle more deeply than others.      Perhaps it is due to partisan politics and political myopia.

Latest news

  • Microsoft India launches AI eyecare research network Microsoft India launches AI eyecare research network

    success. Other areas they will look at include the rate of change of myopia in children, conditions that impact children's eyesight and predictive outcomes of refractive surgery.

  • Lucentis claims speedy FDA review for myopia complication Lucentis claims speedy FDA review for myopia complication

    The US FDA has said it will use its six-month review process for Roche's Lucentis as a treatment for choroidal neovascularization in patients with severe near-sightedness (myopia).

  • Bayer files eye drug Eylea for new use in EU Bayer files eye drug Eylea for new use in EU

    Meanwhile, it has also been filed in Europe for the treatment of diabetic macular oedema and in Japan for choroidal neovascularisation caused by pathologic myopia (mCNV).

  • Novartis licenses Ophthotech eye drug in $1bn deal Novartis licenses Ophthotech eye drug in $1bn deal

    Novartis already sells anti-VEGF (vascular endothelial growth factor) drug Lucentis (ranibizumab) for wet AMD - as well as other indications such as pathological myopia and macular oedema - and achieved sales of

  • NICE backs two eye treatments NICE backs two eye treatments

    The Lucentis guidance covers the use of the medicine to treat sight problems caused by choroidal neovascularisation (CNV) in people with a rare form of short-sightedness known as pathological myopia. ... Pathological myopia is a chronic form of myopia,

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Page & Page

For those who can imagine better, Page & Page is home to meaningful encounters of a marketing, communication and creative kind:...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics